Summary: Jillian Sullivan, PhD reviews how co-morbid clinical conditions, such as autism or anxiety, might affect the presentation and treatment of SPD as well as assist in differential diagnosis. Understand the theory behind clinical co-morbidities and its use for clinicians and researchers in screening for various clinical conditions. Learn about free-to-use and public domain scales for assessments, with an emphasis on autism, ADHD, anxiety, and depression. Includes a videotape analysis and panel discussion of treatment of several cases of children with co-morbid conditions. The focus will be on how different diagnoses impact function and therapeutic implications. Panel includes Lucy Jane Miller PhD, OTR/L, and Sarah A. Schoen PhD, OTR/L.
Level: Intermediate
Intended Audience: Occupational therapists, physical therapists and speech and language pathologists.
Prerequisite: None
Presenter: Jillian Sullivan, PhD, received her doctorate from the University of Cambridge where she studied early brain and cognitive development in Simon Baron-Cohen’s Autism Research Centre with support of a fellowship from the Gates Foundation Trust. She is currently a postdoctoral fellow at STAR Institute with research interests in autism spectrum disorders, social cognition, and emotion regulation.
Learning Objectives:
- Understand the importance of co-morbid difficulties and diagnoses in SPD
- How to add clinical screeners to your assessment of individuals with SPD
- The impact of clinical co-morbid conditions on interventions
Continuing Education: STAR Institute for SPD is an AOTA Approved Provider of Continuing Education. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by AOTA.
Upon full completion of the course video, participants must complete and pass a quiz with at least 80% accuracy to receive a certificate of completion.